Breast cancer - the advent of personalised medicine
From Jillian Hosie
views
comments
From Jillian Hosie
Wednesday 15th February 2017
Join Dr Helen Creedon, and Professor Val Brunton where they will be exploring exciting research aimed at developing new treatment strategies, that are personalised to the individual patient’s cancer, to maximise treatment effectiveness and limit unpleasant side-effects. Most people associate breast cancer with women. However, men can also be affected. Currently, 1 in 8 women in the UK will be affected by breast cancer during their lifetime. Huge steps have been made in understanding some of the complexities underpinning this disease and developing increasingly effective treatment strategies. This started here in Scotland, with Beatson’s discovery that in some women, removal of the ovaries can shrink tumours. Join us to hear about some of the key advances that have led to over 85% of women now living more than 5 years after diagnosis of breast cancer.
The University of Edinburgh is a charitable body, registered in Scotland, with registration number SC005336, VAT Registration Number GB 592 9507 00, and is acknowledged by the UK authorities as a “Recognised body” which has been granted degree awarding powers.
Any views expressed within media held on this service are those of the contributors, should not be taken as approved or endorsed by the University, and do not necessarily reflect the views of the University in respect of any particular issue.
Unless explicitly stated otherwise, all material is copyright © The University of Edinburgh 2021 and may only be used in accordance with the terms of the licence.